C2N Diagnostics Expands the PrecivityAD2™ Alzheimer’s Disease Blood Test Intended Use to Patients 50 Years and Older
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
On Aug. 25, 2025, C2N Diagnostics (C2N) announced lower age limit addresses increasing calls from clinicians seeking access…
On Aug. 22, 2025, the Mayo Clinic announced that its pioneering exploration of stem cell-based therapies for bone…
On Aug. 21, 2025, the Mississippi State Department of Health (MSDH) declared a public health emergency in response…
On Aug. 21, 2025, the Institute for Health Metrics and Evaluation (IHME) announced a recent study aimed to…
On Aug. 20, 2025, two studies led by Johns Hopkins Kimmel Cancer Center, Ludwig Center, and Johns Hopkins Whiting School of…
On Aug. 20, 2025, the National Institute for Health and Care Excellence (NICE) announced that millions of people…
On Aug. 18, 2025, Novo Nordisk announced the launch of a new offer that enables self-paying, eligible, type…
On Aug. 15, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) has approved a…
On Aug. 15, 2025, Precigen announced that the US Food and Drug Administration (FDA) has approved PAPZIMEOS™ (zopapogene imadenovec-drba)…
On Aug. 14, 2025, with help from artificial intelligence, researchers from Massachusetts Institute of Technology (MIT) announced they…
On Aug. 12, 2025, Bayer and Kumquat Biosciences, a clinical-stage biotech company founded by pioneers of the KRAS…
On Aug. 6, 2025, CareDx announced the publication of the Kidney Allograft Outcomes AlloSure Registry (KOAR) study in…
On Aug. 6, 2025, Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ (dordaviprone)…
On Aug. 4, 2025, The Gates Foundation announced a $2.5 billion commitment through 2030 to accelerate research and…
On Aug. 4, 2025, UK Biobank announced it had reached a historic milestone – completing 100,000 whole-body imaging…
On Aug. 4, 2025, the New York City Health Department provided an update on the investigation into a…
On Aug. 1, 2025, Tissium announced it has begun offering surgeons a new solution based on a biopolymer…
On Jul. 31, 2025, Novo Nordisk announced that the US Food and Drug Administration (FDA) approved Alhemo® (concizumab-mtci)…
On Jul. 30, 2025, a study led by Northwestern Medicine shows that most U.S. adults have a “heart…
On Jul. 29, 2025, Stanford Medicine researchers announced the creation a team of virtual scientists backed by artificial…
On Jul. 29, 2025, Texas A&M study finds immersive VR nature experiences improve mood and quality of life….
On Jul. 28, 2025, Kaiser Permanente Washington Health Research Institute (KPWHRI) and Kaiser Permanente Center for Health Research…
On Jul. 25, 2025, the New York City Health Department (Health Department) announced an investigation into a community…
On Jul. 24, 2025, a team of researchers from TGen, part of City of Hope, and Baylor Scott…
On Jul. 24, 2025, an analysis of studies incorporating data from almost 30 million people has highlighted the…
On Jul. 23, 2025, research at Tufts and elsewhere has revealed the eight essential nutrients that make up…
On Jul. 21, 2025, new research led by the Universities of Copenhagen and Bristol shows analysing genes at…
On Jul. 18, 2025, The Environmental Protection Agency (EPA) said it is eliminating its research and development arm…
On Jul. 18, 2025, the U.S. Department of Agriculture said it has fired 70 foreign contract researchers after…
On Jul. 18, 2025, the U.S. Food and Drug Administration (FDA) announced it has placed Sarepta Therapeutics investigational…